Biblio

15 Ergebnisse exportiert:
Autor Titel [ Typ(Desc)] Jahr
Filterkriterien: Autor gleich Jeltsch, M  [Alle Filter deaktivieren]
Conference Proceedings
From molecular biology to a causal treatment of lymphatic system disorders [Internet]. 38. Jahreskongress der Deutschen Gesellschaft für Lymphologie e. V. Halle (Saale), Germany: Deutsche Gesellschaft für Lymphologie; 2014. https://jeltsch.org/abstract-Halle2014
Journal Article
Enholm B, Karpanen T, Jeltsch M, Kubo H, Stenback F, Prevo R, u. a.. Adenoviral expression of vascular endothelial growth factor-C induces lymphangiogenesis in the skin. Circ Res [Internet]. 2001;88(6):623 - 9. http://view.ncbi.nlm.nih.gov/pubmed/11282897PDF Icon Bernd Enholm et al., Circulation Research 2001 (2.93 MB)
Olofsson B, Jeltsch M, Eriksson U, Alitalo K. Current biology of VEGF-B and VEGF-C. Curr Opin Biotechnol [Internet]. 1999;10(6):528 - 35. http://view.ncbi.nlm.nih.gov/pubmed/10600689PDF Icon Birgitta Olofsson et al., Current Opinion in Biotechnology 1999 (577.33 KB)
Chilov D, Kukk E, Taira S, Jeltsch M, Kaukonen J, Palotie A, u. a.. Genomic organization of human and mouse genes for vascular endothelial growth factor C. J Biol Chem [Internet]. 1997;272(40):25176 - 83. http://view.ncbi.nlm.nih.gov/pubmed/9312130PDF Icon Dmitry Chilov et al., The Journal of Biological Chemistry 1997  (517.68 KB)
Jeltsch M, Kaipainen A, Joukov V, Meng X, Lakso M, Rauvala H, u. a.. Hyperplasia of lymphatic vessels in VEGF-C transgenic mice. Science (80- ) [Internet]. 1997;276(5317):1423 - 5. http://view.ncbi.nlm.nih.gov/pubmed/9162011PDF Icon Michael Jeltsch et al., Science 1997 (293.65 KB)
Hiltunen MO, Laitinen M, Turunen MP, Jeltsch M, Hartikainen J, Rissanen TT, u. a.. Intravascular adenovirus-mediated VEGF-C gene transfer reduces neointima formation in balloon-denuded rabbit aorta. Circulation [Internet]. 2000;102(18):2262 - 8. http://view.ncbi.nlm.nih.gov/pubmed/11056103PDF Icon Mikko Hiltunen et al., Circulation 2000 (1.44 MB)
Key molecules in lymphatic development, function, and identification. Annals of Anatomy - Anatomischer Anzeiger [Internet]. 2018;219:25 - 34. http://linkinghub.elsevier.com/retrieve/pii/S0940960218300712PDF Icon 1-s2.0-S0940960218300712-main.pdf (2.19 MB)
Joukov V, Sorsa T, Kumar V, Jeltsch M, Claesson-Welsh L, Cao Y, u. a.. Proteolytic processing regulates receptor specificity and activity of VEGF-C. EMBO J [Internet]. 1997;16(13):3898 - 911. http://view.ncbi.nlm.nih.gov/pubmed/9233800PDF Icon Vladimir Joukov et al., EMBO Journal 1997 (729.21 KB)
Veikkola T, Jussila L, Makinen T, Karpanen T, Jeltsch M, Petrova TV, u. a.. Signalling via vascular endothelial growth factor receptor-3 is sufficient for lymphangiogenesis in transgenic mice. EMBO J [Internet]. 2001;20(6):1223 - 31. http://view.ncbi.nlm.nih.gov/pubmed/11250889PDF Icon Tanja Veikkola et al., EMBO Journal 2001 (491.14 KB)
Achen MG, Jeltsch M, Kukk E, Mäkinen T, Vitali A, Wilks AF, u. a.. Vascular endothelial growth factor D (VEGF-D) is a ligand for the tyrosine kinases VEGF receptor 2 (Flk1) and VEGF receptor 3 (Flt4). Proc Natl Acad Sci U S A [Internet]. 1998;95(2):548 - 53. http://view.ncbi.nlm.nih.gov/pubmed/9435229PDF Icon Marc Achen et al., PNAS 1998 (447.59 KB)
Pepper MS, Mandriota SJ, Jeltsch M, Kumar V, Alitalo K. Vascular endothelial growth factor (VEGF)-C synergizes with basic fibroblast growth factor and VEGF in the induction of angiogenesis in vitro and alters endothelial cell extracellular proteolytic activity. J Cell Physiol [Internet]. 1998;177(3):439 - 52. http://view.ncbi.nlm.nih.gov/pubmed/9808152PDF Icon Michael Pepper et al., Journal of Cellular Physiology 1998 (689.97 KB)
Mandriota SJ, Jussila L, Jeltsch M, Compagni A, Baetens D, Prevo R, u. a.. Vascular endothelial growth factor-C-mediated lymphangiogenesis promotes tumour metastasis. EMBO J [Internet]. 2001;20(4):672 - 82. http://view.ncbi.nlm.nih.gov/pubmed/11179212PDF Icon Stefano Mandriota et al., EMBO Journal 2001 (736.96 KB)
Joukov V, Kaipainen A, Jeltsch M, Pajusola K, Olofsson B, Kumar V, u. a.. Vascular endothelial growth factors VEGF-B and VEGF-C. J Cell Physiol [Internet]. 1997;173(2):211 - 5. http://view.ncbi.nlm.nih.gov/pubmed/9365524PDF Icon Vladimir Joukov et al., Journal of Cellular Physiology 1997 (127.57 KB)
Kukk E, Lymboussaki A, Taira S, Kaipainen A, Jeltsch M, Joukov V, u. a.. VEGF-C receptor binding and pattern of expression with VEGFR-3 suggests a role in lymphatic vascular development. Development [Internet]. 1996;122(12):3829 - 37. http://view.ncbi.nlm.nih.gov/pubmed/9012504PDF Icon Eola Kukk et al., Development 1996 (805.94 KB)
Krebs R, Tikkanen JM, Ropponen JO, Jeltsch M, Jokinen JJ, Ylä-Herttuala S, u. a.. VEGF-C/VEGFR-3 Signaling Regulates Inflammatory Response in Development of Obliterative Airway Disease. Journal of Heart and Lung Transplantation. 2011;30:S118 - S118.